Ritu Suri, MD
Geriatric Medicine · Englewood, NJNPI 1972696409
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 10.5% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 286 payments — averaging $21.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$638
- AstraZeneca$574
- Otsuka America Pharmaceutical, Inc.$540
- Acadia Pharmaceuticals Inc$400
- Eisai Inc.$327
- Neurocrine Biosciences, Inc.$308
- plus $3K from 30 others
What the payments were for
- Food & beverage$6,04899%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 35 | $638 |
| AstraZeneca | 33 | $574 |
| Otsuka America Pharmaceutical, Inc. | 31 | $540 |
| Acadia Pharmaceuticals Inc | 5 | $400 |
| Eisai Inc. | 11 | $327 |
| Neurocrine Biosciences, Inc. | 9 | $308 |
| Boehringer Ingelheim | 5 | $296 |
| Novo Nordisk | 17 | $260 |
| GSK | 18 | $259 |
| Amgen(2 entities) | 6 | $197 |
| Intra-sana Laboratories | 5 | $189 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $175 |
| Amarin Pharma, Inc. | 11 | $168 |
| Pfizer | 5 | $165 |
| Bayer | 8 | $161 |
| Johnson & Johnson | 9 | $145 |
| Avanir Pharmaceuticals, Inc. | 10 | $138 |
| Novartis | 8 | $131 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| Daiichi Sankyo Inc. | 8 | $114 |
| Merck | 2 | $107 |
| Sumitomo Pharma America, Inc. | 4 | $77 |
| Biohaven Pharmaceuticals, Inc. | 1 | $77 |
| Lundbeck LLC | 5 | $74 |
| Sunovion Pharmaceuticals Inc. | 5 | $64 |
| Radius Health, Inc. | 4 | $62 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Biogen | 3 | $43 |
| Insmed, Inc. | 2 | $34 |
| Exact Sciences | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Scpharmaceuticals Inc. | 1 | $27 |
| Mannkind Corporation | 1 | $15 |
| Astellas Pharma US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,090 in reported general payments places this provider in the 90th percentile of 165 geriatric medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 709 | $313,071 |
| JardianceEmpagliflozin | 165 | $116,432 |
| JanuviaSitagliptin Phosphate | 135 | $87,554 |
| FarxigaDapagliflozin Propanediol | 98 | $76,934 |
| XareltoRivaroxaban | 127 | $75,697 |
| TrulicityDulaglutide | 47 | $67,822 |
| MyrbetriqMirabegron | 202 | $62,163 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 13 | $46,270 |
| RexultiBrexpiprazole | 30 | $40,481 |
| Abilify MaintenaAripiprazole | 13 | $36,937 |
| EntrestoSacubitril/Valsartan | 65 | $32,306 |
| Breo ElliptaFluticasone/Vilanterol | 61 | $29,081 |
| LinzessLinaclotide | 38 | $28,029 |
| Divalproex Sodium | 448 | $26,609 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $22,516 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $165 | $313,071709 claims |
| Boehringer IngelheimJardiance, Tradjenta | $296 | $129,161196 claims |
| AstraZenecaFarxiga, Lokelma, Brilinta | $574 | $94,289168 claims |
| MerckJanuvia | $107 | $87,554135 claims |
| Johnson & JohnsonXarelto, Procrit | $145 | $85,607140 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $638 | $83,41861 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $540 | $77,41843 claims |
| Astellas Pharma US IncMyrbetriq | $12 | $62,163202 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $259 | $51,59791 claims |
| NovartisEntresto | $131 | $32,30665 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $77 | $20,94723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 165 geriatric medicine providers in New Jersey.
Other geriatric medicine in Englewood
- Harvey GrossEnglewood$4K
- Albert RiddleHaworth$524K
- Gamil MakarClifton$82K
- Joshua Shua HaimManchester$45K
- Pradip ShahWest Caldwell$27K
- Gregorio GuillenPerth Amboy$8K
- Ketankumar VaidyaEdison$8K
- Cheng-An MaoClifton$8K
- Theresa RedlingLivingston$7K
- Sarita RastogiHackensack$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.